---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-014513"
form_type: "8-K"
ticker: "TWST"
cik: "0001581280"
company_name: "Twist Bioscience Corp"
filed_at: "2023-02-08T23:59:59+00:00"
generated_at: "2026-06-19T21:48:10.744129+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Twist Bio annual meeting elects directors, approves say-on-pay, ratifies auditor

## Summary
- Keith Crandell and Jan Johannessen elected as Class II directors with 33.9M and 32.2M votes for, respectively.
- Non-binding advisory vote to approve NEO compensation passed with 43.4M for, 3.7M against.
- Ratification of Ernst & Young as independent auditor for FY2023 approved with 52.0M votes for, 17.6K against.
- Approximately 91.92% of total outstanding shares were represented at the meeting.

## SEC filing metadata
- accession: 0001104659-23-014513
- form_type: 8-K
- ticker: TWST
- cik: 0001581280
- company_name: Twist Bioscience Corp
- filed_at: 2023-02-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1581280/000110465923014513/0001104659-23-014513-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1581280/000110465923014513/tm235797d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-014513
- JSON: https://secwatch.observer/filing/0001104659-23-014513.json
- Plain text: https://secwatch.observer/filing/0001104659-23-014513.txt

## Key facts
- Shareholder Votes
  Twist Bioscience Corp shareholders approved Ratification of Appointment of Independent Registered Accounting Firm at the 2023-02-07 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-02-07
  source text: Proposal Three — Ratification of Appointment of Independent Registered Accounting Firm The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered accounting firm for the fiscal year ending September 30, 2023 by the following votes: Votes For Votes Against Abstentions 52,003,570 17,623 47,382
  evidence_url: https://www.sec.gov/Archives/edgar/data/1581280/000110465923014513/0001104659-23-014513-index.htm
- Shareholder Votes
  Twist Bioscience Corp shareholders approved Election of Directors at the 2023-02-07 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-02-07
  source text: Proposal One — Election of Directors The Company’s stockholders approved the election of two directors to the Company’s Board of Directors (“Board”) as Class II Directors by the following votes: Nominee Votes For Votes Withheld Broker Non-Votes Keith Crandell 33,891,453 13,264,841 4,912,281 Jan Johannessen 32,240,144 14,916,150 4,912,281
  evidence_url: https://www.sec.gov/Archives/edgar/data/1581280/000110465923014513/0001104659-23-014513-index.htm
- Shareholder Votes
  Twist Bioscience Corp shareholders approved Non-Binding, Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers at the 2023-02-07 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-02-07
  source text: Proposal Two — Non-Binding, Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers (“NEOs”) The Company’s stockholders approved, on a non-binding and advisory basis, a resolution approving the compensation of the Company’s NEOs by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 43,379,295 3,746,996 30,003 4,912,281
  evidence_url: https://www.sec.gov/Archives/edgar/data/1581280/000110465923014513/0001104659-23-014513-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.